Supplements · strategy
Longevity supplement stacks: what happens when you combine unproven things
No longevity supplement stack has been tested as a stack, and even vitamin D alone missed its main targets across more than 5 years in the VITAL trial. Stacks grow because every compound has a mechanism and none has a result decisive enough to remove it.
Why do people stack supplements for longevity?
Because aging has twelve recognized hallmarks in the framework updated in 2023, 10 years after the original list, and no single compound addresses all of them.[1] A longevity supplement stack is usually built from five or more compounds on that logic of coverage.
The flaw is in the premise rather than the logic. Covering several mechanisms is only better if covering one does anything, and for most of these compounds that has not been established. Multiplying an unproven effect by five gives you five unproven effects and a larger bill.
What this page does and does not do
People searching for a supplement stack for longevity rarely meet this objection, because retailers and influencers sell the logic of coverage rather than the results of trials. This page reports what the evidence shows for each piece, and what it cannot show for the combination. It recommends no stack and no dose.
What has each common stack component shown on its own?
Early / mixed evidence Mostly markers that move without outcomes that follow. NAD precursors reliably raise blood NAD, and a trial that raised NAD in human skeletal muscle found no improvement in muscle function.[2]
Spermidine has excellent mechanistic credentials and a delivery problem: a placebo-controlled study found supplementation did not raise plasma spermidine.[3] Fisetin's reputation rests on a mouse study whose lifespan result the rigorous multi-site testing program did not reproduce.[4]
The strongest of the usual items
Urolithin A is the best of them, with randomized human trials reporting improved muscle endurance and biomarker changes, effect sizes that are modest, and a systematic review concluding that healthspan impact remains unestablished.[5]
The item most stacks leave out
Creatine, which has the strongest evidence of the lot for preserving muscle and strength in older adults, is usually absent because it costs pennies and sounds like something for teenagers.[6]
Show the numbers as a table
| When | Event | Detail |
|---|---|---|
| 2019 | NR muscle trial | NAD up, function flat |
| 2019 | VITAL vitamin D | Primary endpoints missed |
| 2023 | Spermidine trial | Plasma level unchanged |
| 2023 | ITP fisetin test | No lifespan extension |
| 2024 | Urolithin A review | Healthspan unproven |
Can you tell which part of a stack is working?
No. If your stack works, you cannot know which component did it, and neither can anyone else, because you changed several variables at once with no control and no measurement.
Why time does not fix it
This is not an abstract complaint. It means a stack cannot accumulate evidence over time, no matter how long you take it or how carefully you feel. Personal experience with a multi-component regimen is uninterpretable by construction, which is precisely why trials test one thing at a time.
Can you measure whether a stack is doing anything?
Barely, because the targets a stack claims to move are mostly out of reach.
| Target | What measuring it requires |
|---|---|
| Autophagy | Cannot be measured in a living person |
| Senescent cell burden | Tissue analysis |
| Tissue NAD | A biopsy |
| Biological age | A test whose retest error is comparable to the changes people celebrate |
So the stack is unfalsifiable in practice. Nothing you can buy will tell you it is not working, which is an uncomfortable property for something you intend to take for decades. Our page on what biological age tests can and cannot measure covers that in detail.
What have large supplement trials found?
Less than expected, repeatedly. The largest randomized trials of individual supplements in general populations have often failed to find benefits that observational data predicted, including the vitamin D and omega-3 arms of a very large trial that missed their primary endpoints.[7]
That history is directly relevant to any longevity supplement stack. Its compounds have far less human data than vitamin D had when those trials began, and the base rate for supplements surviving proper testing is not encouraging.
Vitamin D and omega-3 already had their big trial
Vitamin D and fish oil are the two items most often sitting at the base of a stack, and they are also the rare supplements tested at scale. VITAL randomized 25,871 US adults to 2,000 IU of vitamin D3 daily or placebo and followed them for a median 5.3 years (per Manson et al., 2019).[8]
The result was close to a null on every main outcome. Hazard ratios sat at 0.96 for invasive cancer, 0.97 for major cardiovascular events and 0.99 for death from any cause, where 1.00 means no difference. A lower cancer death rate appeared only as a secondary signal.
Show the numbers as a table
| Measure | Value |
|---|---|
| Invasive cancer | HR 0.96 |
| Cardiovascular events | HR 0.97 |
| Death, any cause | HR 0.99 |
| No effect | 1.00 |
For your decision, the lesson is about base rates. If a well-funded trial of this size could not show a primary benefit for a familiar vitamin, a combination of far less studied compounds deserves more caution, not less.
- What this does not say:
- Participants were mostly not vitamin D deficient; people with low levels may benefit, and cancer-mortality signals are secondary.
Do stack ingredients interact with each other?
Some do, and almost none of the combinations has been studied. Resveratrol interacts with anticoagulants and berberine shifts glucose handling. The rare exception is a trial that gave nicotinamide riboside alone and with resveratrol, and an NR researcher describes the result below.
The addition of resveratrol to nicotinamide riboside degraded the positive effects of nicotinamide riboside on the six-minute walk test.
Low risk is not no risk
The risk is still low in absolute terms, because most of these compounds are mild. It is not zero, and it is invisible.
Is a longevity supplement stack worth taking?
Only as a small, affordable bet on two or three plausible mechanisms, bought with clear eyes about the evidence. That is a legitimate personal choice rather than a demonstrated protocol, and this page is not an argument against it. It belongs in a conversation with a clinician who knows your medications.
When the stack becomes a protocol
If it is a twelve-item protocol costing several hundred dollars a month, bought as something demonstrated, the evidence does not support that belief for any component.
Where to compare the evidence
Our reviews of the supplement evidence compound by compound and the NAD category specifically apply the same standard, and the Blueprint page covers what happens when this approach is taken to its limit.
Frequently asked questions
Does taking a stack for years make your own experience more reliable?
No. With several variables changed at once and no control, a multi-component regimen cannot accumulate evidence over time, however long it is taken. That is why trials test one compound at a time.
Do longevity supplement stacks work?
No stack has been tested as a stack. Every combination in circulation is assembled from individual compounds, most of which have not demonstrated a benefit alone, and combining unproven things does not produce a proven thing.
Is there any evidence for combining supplements?
Essentially none for these combinations. Trials test single compounds because that is the only way to attribute an effect. A stack is untestable by design: if something changes, nothing tells you which component did it.
What would a defensible stack contain?
Judged strictly on evidence, mostly boring things: creatine if you do resistance training, vitamin D if you are deficient, omega-3 for cardiovascular reasons in some people, and protein sufficiency. That list disappoints everyone and it is what the evidence supports.
Why do stacks keep growing?
Because each compound has a plausible mechanism and no compound has a disconfirming result strong enough to remove it. Absence of proof cuts both ways, and in practice it means nothing ever leaves the stack.
Do the compounds interact with each other?
Nobody knows, which is its own problem. Resveratrol affects clotting, several compounds affect glucose handling, and almost none of these combinations has been studied for interaction; the one NR-plus-resveratrol trial found the pair did worse than NR alone. More components means more unmodeled interactions.
Is a stack safer than a drug?
Usually, and that is the honest appeal. Most of these compounds have mild side effect profiles at ordinary doses. Low risk is a reason not to worry, not a reason to expect a benefit.
What does a typical stack cost?
Several hundred dollars a month once it includes NAD precursors and urolithin A, which are the expensive components. That spending has an opportunity cost against things with better evidence, including a gym membership and better food.
Should I take everything Bryan Johnson takes?
That protocol is one person running hundreds of simultaneous interventions with no control group, which makes it uninterpretable by design. Copying an uninterpretable experiment does not transfer a benefit that was never demonstrated.
Which compound in a typical stack has the best evidence?
Creatine, and it is usually not in the stack because it is cheap and unglamorous. Among the longevity-branded compounds, urolithin A has the most real human trial data, with modest effects and a single dominant sponsor.
Which has the weakest?
Spermidine has the strangest problem: two studies found supplementation barely raises plasma spermidine. Fisetin has the most awkward one: the rigorous multi-site mouse program did not reproduce its lifespan result.
Should stacks be cycled?
No cycling schedule for any of these compounds has been tested. Cycling advice is reasoning by analogy from pharmacology that does not necessarily apply.
How would I know if my stack was working?
You would not. There is no accessible marker for autophagy, senescent cell burden or tissue NAD, and biological age tests have measurement error comparable to the changes people celebrate. The stack is unfalsifiable in practice.
What is the sensible approach?
Decide what you are buying. A small number of compounds as an affordable bet on plausible mechanisms is defensible. A twelve-item stack purchased as a longevity protocol is buying certainty that nothing in the evidence supports.
References
8 sources, all link-checked; oldest check
- Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Elhassan YS et al. Cell Reports 2019;28(7):1717–1728.e6.Raised muscle NAD+ metabolites without a matching change in functional performance.Verified Sep 15, 2026
- High-dose spermidine supplementation does not increase spermidine levels in blood plasma and saliva of healthy adults. Senekowitsch S et al. 2023 (cited 52).Placebo-controlled: supplementation significantly raised plasma spermine but did not raise spermidine in plasma or saliva.Verified Sep 15, 2026
- Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002, dimethyl fumarate and mycophenolic acid do not. Harrison DE et al. GeroScience 2023 (NIA Interventions Testing Program; cited 64).The most rigorous multi-site mouse lifespan program tested fisetin and found no lifespan extension.Verified Sep 15, 2026
- Targeting aging with urolithin A in humans: a systematic review. Kuerec AH et al. Ageing Research Reviews 2024 (cited 84).Systematic review of human trials; potential effects on inflammation, muscle strength and endurance, with impact on healthspan not established.Publisher blocks automated checks · last tried Sep 15, 2026
- Effectiveness of creatine supplementation on aging muscle and bone: focus on falls prevention and inflammation. Candow DG et al. Journal of Clinical Medicine 2019 (cited 247).Review concluding creatine increases aging muscle mass and strength and may reduce falls risk, particularly alongside resistance training.Verified Sep 15, 2026
- Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses. Manson JE et al. J Steroid Biochem Mol Biol 2020 (cited 213).Pooled reading: a significant reduction in cancer mortality but not in cancer incidence or cardiovascular endpoints.Verified Sep 15, 2026
- Vitamin D supplements and prevention of cancer and cardiovascular disease. Manson JE et al. New England Journal of Medicine 2019 (VITAL; cited 2,159).25,871 participants, median 5.3 years: vitamin D did not lower the incidence of invasive cancer or cardiovascular events versus placebo.Publisher blocks automated checks · last tried Sep 15, 2026
- Hallmarks of aging: an expanding universe. López-Otín C et al. Cell 2023;186(2):243–278.Updated framework: twelve hallmarks.Publisher blocks automated checks · last tried Sep 15, 2026
Every link above is re-requested on a schedule by an automated checker; the date shown is when it last answered. Publishers that block automated requests are marked as such rather than reported broken. Our editorial standards explain how a source gets cited here in the first place.
Filed by the Rapamycin.store evidence desk. Each source is re-checked when the page is reviewed.
Own a longevity or health brand?
Rapamycin.store publishes sponsored and guest posts on an aged, topically-relevant domain, and offers display advertising. Tell us what you want to promote and we'll send our current options.